In This Section
Peptide Receptor Radiotherapy for Neuroendocrine Tumors
Webinar for patients and caregivers on what PRRT is, how it works, where it is being used, and who is eligible to receive it.
Peptide Receptor Radiotherapy Webinar
In this patient-focused webinar, Drs. Wolin and Mittra explain what PRRT is, how it works, where it is being used, and who is eligible to receive it.
About the Speakers
Josh Mailman
President, NorCal CarciNET
Past Chair of SNMMI Patient Advocacy Advisory Board
Edward M. Wolin, MD
Director of Neuroendocrine and GI Oncology
Director of Clinical Research
University of Kentucky
Lexington, KY
Erik Mittra, MD, PhD
Associate Professor of
Radiology & Nuclear Medicine
Oregon Health & Science University
Portland, OR
Chair, SNMMI Targeted Radioisotope Therapy Working Group